Citation: Godwin Oligbu. Higher valent Pneumococcal Conjugate Vaccines: is it a roller coaster?[J]. AIMS Public Health, 2020, 7(1): 29-32. doi: 10.3934/publichealth.2020004
| [1] | Mitchell Ratner, Chih-Chieh (Jason) Chiu . Portfolio Effects of VIX Futures Index. Quantitative Finance and Economics, 2017, 1(3): 288-299. doi: 10.3934/QFE.2017.3.288 |
| [2] | Akash Deep . Advanced financial market forecasting: integrating Monte Carlo simulations with ensemble Machine Learning models. Quantitative Finance and Economics, 2024, 8(2): 286-314. doi: 10.3934/QFE.2024011 |
| [3] | Lucjan T. Orlowski, Monika Sywak . Wavering interactions between commodity futures prices and us dollar exchange rates. Quantitative Finance and Economics, 2019, 3(2): 221-243. doi: 10.3934/QFE.2019.2.221 |
| [4] | Gabriel Frahm . How often is the financial market going to collapse?. Quantitative Finance and Economics, 2018, 2(3): 590-614. doi: 10.3934/QFE.2018.3.590 |
| [5] | Etti G. Baranoff, Patrick Brockett, Thomas W. Sager, Bo Shi . Was the U.S. life insurance industry in danger of systemic risk by using derivative hedging prior to the 2008 financial crisis?. Quantitative Finance and Economics, 2019, 3(1): 145-164. doi: 10.3934/QFE.2019.1.145 |
| [6] | Cunyi Yang, Li Chen, Bin Mo . The spillover effect of international monetary policy on China's financial market. Quantitative Finance and Economics, 2023, 7(4): 508-537. doi: 10.3934/QFE.2023026 |
| [7] | Dimitra Loukia Kolia, Simeon Papadopoulos . The levels of bank capital, risk and efficiency in the Eurozone and the U.S. in the aftermath of the financial crisis. Quantitative Finance and Economics, 2020, 4(1): 66-90. doi: 10.3934/QFE.2020004 |
| [8] | Andrea Ferrario, Massimo Guidolin, Manuela Pedio . Comparing in- and out-of-sample approaches to variance decomposition-based estimates of network connectedness an application to the Italian banking system. Quantitative Finance and Economics, 2018, 2(3): 661-701. doi: 10.3934/QFE.2018.3.661 |
| [9] | Chen Li, Xiaohu Li . Stochastic arrangement increasing risks in financial engineering and actuarial science – a review. Quantitative Finance and Economics, 2018, 2(1): 675-701. doi: 10.3934/QFE.2018.1.190 |
| [10] | Jyh-Horng Lin, Shi Chen, Jeng-Yan Tsai . How does soft information about small business lending affect bank efficiency under capital regulation?. Quantitative Finance and Economics, 2019, 3(1): 53-74. doi: 10.3934/QFE.2019.1.53 |
| [1] |
Kelly DF, Pollard AJ, Moxon ER (2005) Immunological memory: the role of B cells in long-term protection against invasive bacterial pathogens. JAMA 294: 3019-3023. doi: 10.1001/jama.294.23.3019
|
| [2] |
Avery OT, Dubos R (1931) The protective action of a specific enzyme against type III pneumococcus infections in mice. J Exp Med 54: 73-89. doi: 10.1084/jem.54.1.73
|
| [3] |
Schlesinger Y, Granoff DM, Murphy TV, et al. (1992) Avidity and bactericidal activity of antibody elicited by different Haemophilus influenzae type b conjugate vaccines. JAMA 267: 1489-1494. doi: 10.1001/jama.1992.03480110065035
|
| [4] |
McVernon J, Mitchison NA, Moxon ER (2004) T helper cells and efficacy of Haemophilus influenzae type b conjugate vaccination. Lancet Infect Dis 4: 40-43. doi: 10.1016/S1473-3099(03)00859-4
|
| [5] |
Robbins JB, Austrian R, Lee CJ, et al. (1983) Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groups. J Infect Dis 148: 1136-1159. doi: 10.1093/infdis/148.6.1136
|
| [6] |
Jacobs M (2008) “Antimicrobial-resistant Streptococcus pneumoniae: Trends and management.”. Expert Rev Anti Infect Ther 6: 619-635. doi: 10.1586/14787210.6.5.619
|
| [7] | Yildirim I, Stevenson A, Hsu KK, et al. (2012) Evolving picture of invasive pneumococcal disease in Massachusetts children: a comparison of disease in 2007–2009 with earlier periods. Pediatr Infect Dis J 31: 1016-1021. |
| [8] |
Waight PA, Andrews NJ, Ladhani SN, et al. (2015) Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: An observational cohort study. Lancet Infect Dis 15: 535-543. doi: 10.1016/S1473-3099(15)70044-7
|
| [9] |
Conklin L, Loo JD, Kirk J, et al. (2014) Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on vaccine-type invasive pneumococcal disease among young children. Pediatr Infect Dis J 33: S109-S118. doi: 10.1097/INF.0000000000000078
|
| [10] |
O'Brien KL, Wolfson LJ, Watt JP, et al. (2009) Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 374: 893-902. doi: 10.1016/S0140-6736(09)61204-6
|
| [11] |
Ladhani SN, Collins S, Djennad A, et al. (2018) Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000–17: a prospective national observational cohort study. Lancet Infect Dis 18: 441-451. doi: 10.1016/S1473-3099(18)30052-5
|
| [12] | European Centre for Disease Prevention and ControlInvasive pneumococcal disease. Stockholm: . Available from: https://ecdc.europa.eu/en/publication-data/invasive-pneumococcal-disease-annual-epidemiological-report-2017. |
| [13] |
Greenberg D, Hoover PA, Vesikari T, et al. (2018) Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV15) in healthy infants. Vaccine 36: 6883-6891. doi: 10.1016/j.vaccine.2018.02.113
|
| [14] |
McFetridge R, Sobanjo-ter Meulen A, Folkerth SD, et al. (2018) Safety, tolerability, and immunogenicity of 15-valent pneumococcal conjugate vaccine in healthy adults. Vaccine 33: 2793-2799. doi: 10.1016/j.vaccine.2015.04.025
|
| [15] |
Makwana A, Sheppard C, Borrow R, et al. (2018) Characteristics of Children With Invasive Pneumococcal Disease After the Introduction of the 13-valent Pneumococcal Conjugate Vaccine in England and Wales, 2010–2016. Pediatr Infect Dis J 37: 697-703. doi: 10.1097/INF.0000000000001845
|
| [16] | Oligbu G, Collins S, Sheppard C, et al. (2018) Risk of Invasive Pneumococcal Disease in Children with Sickle Cell Disease in England: A National Observational Cohort Study, 2010–2015. Arch Dis Child 103: 643-647. |
| [17] |
Oligbu G, Fallaha M, Pay LLS (2019) Risk of invasive pneumococcal disease in children with sickle cell disease in the era of conjugate vaccines: a systematic review of the literature. Br J Haematol 185: 743-751. doi: 10.1111/bjh.15846
|
| [18] |
Thompson A, Lamberth E, Severs J, et al. (2019) Phase 1 trial of a 20-valent pneumococcal conjugate vaccine in healthy adults. Vaccine 37: 6201-6207. doi: 10.1016/j.vaccine.2019.08.048
|
| [19] |
Ladhani SN, Ramsay ME (2015) Editorial commentary: the story of Sisyphus: why we need a universal pneumococcal vaccine to replace current conjugate vaccines. Clin Infect Dis 776-778. doi: 10.1093/cid/civ371
|
| 1. | N.I. Yashina, O.I. Kashina, S.S. Petrov, N.N. Pronchatova-Rubtsova, Developing the methodology of early diagnosis of financial crises using a system of signaling economic indicators, 2020, 13, 20734484, 362, 10.24891/fa.13.4.362 | |
| 2. | Yue Liu, Hao Dong, Pierre Failler, The Oil Market Reactions to OPEC’s Announcements, 2019, 12, 1996-1073, 3238, 10.3390/en12173238 | |
| 3. | Lean Yu, Xiaowen Huang, Hang Yin, Can machine learning paradigm improve attribute noise problem in credit risk classification?, 2020, 70, 10590560, 440, 10.1016/j.iref.2020.08.016 | |
| 4. | Luís Almeida, Francisco Sousa, Determinants of bank profitability in Portugal: Insights from a period of sectoral transformation, 2025, 9, 2573-0134, 425, 10.3934/QFE.2025014 |
Godwin Oligbu. Higher valent Pneumococcal Conjugate Vaccines: is it a roller coaster?[J]. AIMS Public Health, 2020, 7(1): 29-32. doi: 10.3934/publichealth.2020004
DownLoad: